Trials / Completed
CompletedNCT01170611
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease
Prevention of Atrial Arrhythmia in Patients Without AV Conduction Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- LivaNova · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation is a prospective, single-blinded, randomized trial. The primary objective concerns the safety and effectiveness of the AAIsafeR mode with the preventive algorithms.
Detailed description
In this study, patients are randomized to DDD mode, AAIsafeR mode, or AAIsafeR mode plus atrial arrhythmia preventive algorithms. The atrial arrhythmia (AA) burden serves as the primary measure of effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PACEMAKER SYMPHONY 2550 |
Timeline
- Start date
- 2004-07-01
- Completion
- 2007-01-01
- First posted
- 2010-07-27
- Last updated
- 2010-07-27
Locations
52 sites across 8 countries: United States, Belgium, France, Germany, Italy, Monaco, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01170611. Inclusion in this directory is not an endorsement.